Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 371

1.

Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.

Jiajue R, Jiang Y, Wang O, Li M, Xing X, Cui L, Yin J, Xu L, Xia W.

Osteoporos Int. 2014 Aug;25(8):1999-2005. doi: 10.1007/s00198-014-2714-5.

PMID:
24760246
2.

The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.

Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L.

Menopause. 2011 Nov;18(11):1237-43. doi: 10.1097/gme.0b013e31821d7ff7.

PMID:
21747303
3.

Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

Tamaki J, Iki M, Kadowaki E, Sato Y, Chiba Y, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H; JPOS Study Group..

Osteoporos Int. 2013 Mar;24(3):887-97. doi: 10.1007/s00198-012-2106-7.

PMID:
22885773
4.
5.

[The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].

Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B.

Tunis Med. 2014 May;92(5):304-10. French.

6.

Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.

Shigdel R, Osima M, Ahmed LA, Joakimsen RM, Eriksen EF, Zebaze R, Bjørnerem Å.

Bone. 2015 Dec;81:1-6. doi: 10.1016/j.bone.2015.06.016.

PMID:
26112819
7.

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.

Cosman F, Eriksen EF, Recknor C, Miller PD, Guañabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S.

J Bone Miner Res. 2011 Mar;26(3):503-11. doi: 10.1002/jbmr.238.

8.

[Osteoporosis and arterial stiffness: study of 103 women with mild to moderate risk of cardiovascular disease].

Ageev FT, Barinova IV, Seredenina EM, Orlova IaA, Kuz'mina AE, Masenko VP, Kochetov AG.

Kardiologiia. 2013;53(6):51-8. Russian.

PMID:
23953046
9.

[Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].

Zhang LL, Jiang XF, Ai HZ, Jin ZD, Xu JX, Wang B, Xu W, Xie ZG, Zhou HB, Dong QR, Xu YJ.

Zhonghua Wai Ke Za Zhi. 2013 Jun 1;51(6):518-21. Chinese.

PMID:
24091266
10.

Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.

Anastasilakis AD, Polyzos SA, Makras P, Gkiomisi A, Bisbinas I, Katsarou A, Filippaios A, Mantzoros CS.

Osteoporos Int. 2014 May;25(5):1633-42. doi: 10.1007/s00198-014-2673-x.

PMID:
24599275
11.

Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis.

Cairoli E, Eller-Vainicher C, Ulivieri FM, Zhukouskaya VV, Palmieri S, Morelli V, Beck-Peccoz P, Chiodini I.

Osteoporos Int. 2014 Apr;25(4):1401-10. doi: 10.1007/s00198-014-2619-3.

PMID:
24510095
12.

A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study.

Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Chen Q, Xu L.

Bone. 2012 Apr;50(4):917-24. doi: 10.1016/j.bone.2012.01.003.

PMID:
22270056
13.

Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.

Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD.

Osteoporos Int. 2013 Feb;24(2):489-94. doi: 10.1007/s00198-012-1978-x.

PMID:
22525978
14.

Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes.

Zhou Y, Li Y, Zhang D, Wang J, Yang H.

Diabetes Res Clin Pract. 2010 Dec;90(3):261-9. doi: 10.1016/j.diabres.2010.09.013.

PMID:
20950884
15.

Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.

Li M, Lv F, Zhang Z, Deng W, Li Y, Deng Z, Jiang Y, Wang O, Xing X, Xu L, Xia W.

Osteoporos Int. 2016 May;27(5):1907-16. doi: 10.1007/s00198-015-3475-5.

PMID:
26733373
16.

Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.

Verit FF, Geyikli I, Yazgan P, Celik A.

Arch Gynecol Obstet. 2006 Jun;274(3):133-7.

PMID:
16532321
17.
18.
19.

Prevalence of non-fracture short vertebral height is similar in premenopausal and postmenopausal women: the osteoporosis and ultrasound study.

Ferrar L, Roux C, Reid DM, Felsenberg D, Glüer CC, Eastell R.

Osteoporos Int. 2012 Mar;23(3):1035-40. doi: 10.1007/s00198-011-1657-3.

PMID:
21611843
20.

The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.

Zhukouskaya VV, Eller-Vainicher C, Gaudio A, Privitera F, Cairoli E, Ulivieri FM, Palmieri S, Morelli V, Grancini V, Orsi E, Masserini B, Spada AM, Fiore CE, Chiodini I.

Osteoporos Int. 2016 Jan;27(1):49-56. doi: 10.1007/s00198-015-3212-0. Erratum in: Osteoporos Int. 2016 Jan;27(1):421. Ellen-Vainicher, C [Corrected to Eller-Vainicher, C].

PMID:
26138582
Items per page

Supplemental Content

Support Center